We measured high-sensitivity cardiac troponin I ( hsTnI ) in 12956 and BNP in 11076 participants without cardiovascular disease in the Justification for the Use of Statins in Prevention : An Intervention Trial Evaluating Rosuvastatin ( JUPITER ) trial before randomization to rosuvastatin 20 mg/d or placebo .